Mark Berger

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Berger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Berger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Genprex, Inc. Chief Medical Officer Common Stock 28,860 $13,852 $0.4800 22 Dec 2025 Direct
Actinium Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 67,164 01 Sep 2021 Direct

Insider Reports Filed by Mark Berger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GNPX Genprex, Inc. 22 Dec 2025 1 $0 4 Chief Medical Officer 23 Dec 2025, 17:35
GNPX Genprex, Inc. 30 Jun 2025 1 -$1,026 4 Chief Medical Officer 01 Jul 2025, 17:52
GNPX Genprex, Inc. 18 Feb 2025 1 -$240 4 Chief Medical Officer 19 Feb 2025, 20:01
GNPX Genprex, Inc. 05 Dec 2024 1 $0 4 Chief Medical Officer 06 Dec 2024, 17:48
GNPX Genprex, Inc. 18 Feb 2024 1 -$5,804 4 Chief Medical Officer 21 Feb 2024, 16:34
GNPX Genprex, Inc. 18 Feb 2023 1 $0 4 Chief Medical Officer 22 Feb 2023, 17:35
GNPX Genprex, Inc. 04 Feb 2022 1 $0 4 Chief Medical Officer 08 Feb 2022, 15:32
GNPX Genprex, Inc. 27 Sep 2021 1 $0 4 Chief Medical Officer 28 Sep 2021, 16:26
GNPX Genprex, Inc. 27 Sep 2021 0 $0 3 Chief Medical Officer 28 Sep 2021, 16:23
ATNM Actinium Pharmaceuticals, Inc. 01 Sep 2021 1 $0 4 Chief Medical Officer 03 Sep 2021, 17:04